Medical Advisory Board

Paul Romesser, MD

Assistant Professor
Radiation Oncology
Memorial Sloan Kettering

Dr. Romesser earned a combined BA/MD at Boston University. He studied at the National Cancer Institute (NCI) as a Howard-Hughes Medical Institute and National Institutes of Health Research Scholar. He completed residency in Radiation Oncology at Memorial Sloan Kettering Cancer Center, where he was Chief Resident. He is currently an Assistant Professor in Radiation Oncology at Memorial Sloan Kettering Cancer Center and a physician scientist with an interest in developing novel radiation sensitizers for gastrointestinal tumors. He is a member of the NRG; (NSABP/RTOG/GOG) Oncology colorectal and non-colorectal committees and the National Cancer Institute (NCI) Rectal-Anal Task Force. His work has been published in Nature, Science, Cell, The Lancet, Oncology, Clinical Cancer Research, International Journal of Radiation Oncology, Biophysics, and Cancer.

Judith Smith, PharmD, BCOP

Professor
University of Texas
McGovern Medical School

Dr. Smith is an Associate Professor in the Department of Obstetrics, Gynecology and Reproductive Sciences at UTHealth McGovern Medical School and Director of the Women’s Health Integrative Medicine Research Program. She also is an oncology clinical pharmacy specialist at the UTHealth-Memorial Hermann Cancer Center. She received a Bachelor of Science in Pharmacy and Doctor of Pharmacy from Union University Albany College of Pharmacy. She completed residency in Pharmacy Practice and Oncology Pharmacy Practice at National Institutes of Health (NIH) followed by a fellowship in Clinical Pharmacology at UT M.D. Anderson Cancer Center (UTMDACC).

Previously she was a Faculty member in the Department of Gynecologic Oncology at UTMDACC. Dr. Smith is an active member of many pharmacy professional organizations. She has been Board Certified in Oncology Pharmacy and Certified Professional in Healthcare Quality. Her research mission is to advance the progress of the safe and effective use of nutritional and herbal supplements with pharmacologic modalities as it relates to women’s health and cancer through innovative thinking, systematic methodology and collaborative interactions throughout the UTHealth System and global research community.

Carl McDougal

Associate Clinical Professor
Weill Medical College
Cornell University

Dr. McDougall received his undergraduate degree from Rochester Institute of Technology and his medical degree from Weill Cornell Medical College. His medical residency was completed at the Montefiore Hospital and Medical Center at Albert Einstein College of Medicine and his fellowship in gastroenterology at Weill Cornell Medical College.

Dr. McDougall has received a number of awards: the Leo Davidoff Society Award for excellence in teaching medical students of Albert Einstein College of Medicine; an Excellence in Teaching Award at Weill Cornell Medical College.

Dr. McDougall is a board-certified gastroenterologist. His practice is currently located in Midtown Manhattan where he continues to provide a wide array of gastroenterological services to patients with related disorders and diseases.

He has published extensively in peer review journals, and is an active member in a number of medical societies, including The American Gastroenterological Association, The American College of Gastroenterology, and The New York Society of Gastrointestinal Endoscopy.

Aaron Katz, MD, FACS

Chairman of Urology
Hospital Professor of Urology
NYU School of Medicine

Dr. Katz established and serves as the Program Director of Urology Residency Program at NYU Long Island School of Medicine and is an attending physician at Winthrop Urology, a progressive urology practice with offices in Garden City, Long Island and the Upper East Side of Manhattan. Prior to joining Winthrop, he was a Professor of Urology at Columbia University Hospital College of Physicians and Surgeons and was the Director of the Center for Holistic Urology, a Center which he established in 1998 performing basic research and clinical trials to investigate the role of natural therapies within urology.

Dr. Katz is also recognized as an expert in the field of prostate cryosurgery. In the early 1990s, he began using cryosurgery to treat and cure prostate cancers. His pioneer work in advancing the technology helped Medicare approve this therapy for treating radiation-recurrent tumors. Dr. Katz has trained over 100 Urologists internationally to perform cryosurgery in their hospitals. Dr. Katz has published more than 150 scientific articles in peer-reviewed journals, and has written five chapters for Urologic textbooks. He is currently the host of "Katz’s Corner", a men’s health radio program aired every Sunday morning at 7 a.m. on WABC Radio.

Stephen E. Goldstone, MD, FACS

Assistant Clinical Professor of Surgery
Icahn School of Medicine
Mount Sinai

Dr. Goldstone is an active member of the American Society of Colon and Rectal Surgeons. He attended the State University of NY at Albany, graduated Summa Cum Laude and was elected to Phi Beta Kappa. He attended the Albert Einstein College of Medicine where he was elected to Alpha Omega Alpha, the medical honor society. He completed a surgery residency at the Albert Einstein College of Medicine/Montefiore Medical Center and served as Chief Resident for the last two years of his residency.

Dr. Goldstone has spoken at conferences around the world and has done extensive research on human papillomavirus (HPV). His work has been published in many prestigious medical journals. He has developed a surgical technique to treat anal HPV dysplasia and is currently involved in testing both prevention and treatment procedures for HPV. He is a member of the AIDS Malignancy Consortium. Dr. Goldstone is an expert on gay men’s health and authored the best-selling book The Ins and Outs of Gay Sex -- A Medical Handbook for Men. He is past-president of the Albert Einstein College of Medicine Alumni Board of Governors. He is the immediate past president of the International Anal Neoplasia Society and has a surgical practice in New York City.

Michael Gaisa, MD

Associate Professor of Medicine
Icahn School of Medicine
Mount Sinai

Dr. Gaisa has a strong interest in HIV infection, sexually transmitted infections, anogenital HPV infection and men's health. He is an associate professor of medicine at the Icahn School of Medicine at Mount Sinai in New York. He has more than 10 years of experience in conducting high-resolution anoscopies for anal dysplasia screening and cancer prevention. He directs the anal dysplasia program for the Mount Sinai Health System and is part of a prolific clinical research group.

Karyn A. Goodman, MD, MS

Professor and Vice Chair of
Research in Radiation Oncology
Icahn School of Medicine, Mt. Sinai

Dr. Goodman is Professor and Vice Chair of Research in the Department of Radiation Oncology at the Icahn School of Medicine at Mount Sinai and serves as the Associate Director of Clinical Research in the Tisch Cancer Institute.  She recently moved to Mount Sinai from the University of Colorado and was previously the head of GI Radiation Oncology at Memorial Sloan Kettering Cancer Center.  Dr. Goodman obtained her undergraduate and medical degrees from Stanford University. She completed her residency training in Radiation Oncology at Memorial Sloan-Kettering Cancer Center and earned a Masters in Epidemiology at the Harvard School of Public Health in 2006. 

Dr. Goodman’s interests include image-guide radiation therapy, stereotactic body radiotherapy, and intensity modulated radiotherapy treatment planning for gastrointestinal cancers with the intent of reducing toxicity and improving results with radiation therapy.  She has also focused her research on quality of life and late effects after radiotherapy. In addition to her interest in technical advances in radiation oncology, she is involved in the development of therapeutic protocols combining radiation, chemotherapy, targeted agents, and immunotherapy for gastrointestinal cancers.

Dr. Goodman is an internationally recognized expert in gastrointestinal cancers and has served in numerous leadership roles on multiple national committees. She now serves as the Co-Chair of the NCI’s Gastrointestinal Steering Committee. She serves as the national Radiation Oncology principal investigator of the RTOG/NRG 0848 study, a phase III trial evaluating the use of post-operative radiotherapy for pancreatic cancer and the national study chair for the CALGB/Alliance 80803 trial evaluating PET-directed therapy for esophageal canceresophageal cancer. She has published more than 150 peer-reviewed scientific articles, review articles, and chapters.

Marshall Posner, MD

Professor of Medicine
Icahn School of Medicine
Mount Sinai

Dr. Posner is Professor of Medicine Icahn School of Medicine at Mount Sinai, NY (2010). He is Medical Director of the Head and Neck Oncology Program (2010), Associate Director of the Center for Personalized Cancer Therapeutics (2016), and co-Director of the Cancer Clinical Investigation Program (2018) for the Mount Sinai NCI - National Cancer Institute designated Cancer Center. He was also the Medical Director of the Cancer Clinical Trials Office (2010-2015) at Mount Sinai. He graduated from Yale University with a BA in psychology (1971) and Tufts Medical School with an MD (1975). He completed residency in Internal Medicine at Boston City Hospital (1978) and a medical oncology fellowship at Dana Farber Cancer Institute (1981). He was an Instructor in Medical Oncology at DFCI and Harvard (1981-1983). He was an Assistant Professor of Medicine at Roger Williams Medical Center, and Brown University (1983-1991); an Assistant (1991) and Associate Professor (1994) of medicine at the Beth Israel Deaconess Medical Center, Harvard Medical School. He served as Medical Director of the Head and Neck Oncology Program and Associate Professor of Medicine at the Dana-Farber Cancer Institute, Harvard Medical School (1995-2010).

Dr. Posner has published more than 275 peer-reviewed basic laboratory and clinical studies and multiple reviews and abstracts. He has been principal investigator of RO1 grants in immunology and HIV and was Director of the Human Monoclonal Antibody Laboratory at the Roger Williams Medical Center, Brown University (1983-1991), and Beth Israel Deaconess Medical Center, Harvard Medical School (1991-2010). Dr. Posner has been the principal investigator on numerous therapeutic and laboratory studies of immunotherapy and monoclonal antibodies in pemphigus, HIV, and nasopharynx cancer. He has been principal investigator on Phase 1, 2 and 3 clinical trials in Head and Neck Cancer and other cancers. He holds multiple patents in human monoclonal antibodies to infectious agents. He has a major interest in the immunobiology and therapeutics of Human Papillomavirus and oropharynx cancer and has served on numerous advisory boards for drug development and Data Safety Monitoring Boards for clinical trials.

Keith Sigel, MD, Ph.D

Associate Professor
Icahn School of Medicine
Mount Sinai

Dr. Sigel is an Associate Professor in the Divisions of General Internal Medicine and Infectious Diseases at the Icahn School of Medicine at Mount Sinai. Dr. Sigel received his BS, MPH, and MD degrees from the University of North Carolina at Chapel Hill and his PhD and internal medicine and infectious diseases training from the Icahn School of Medicine at Mount Sinai. Dr. Sigel is a clinical researcher and epidemiologist with a primary research interest in clinical factors related to the abnormal biology of anal cancer in patients with HIV. He co-directs the Cancer Core of the Veterans Aging Cohort and is the principal investigator of two NIH funded studies to evaluate cancer screening and cancer treatment in people with HIV. He is a member of the Mount Sinai Anal Cancer Screening Program and has published numerous studies related to the early detection of anal cancer.

Marcelo W. B. Araujo

D.D.S., M.S., Ph.D.
Chief Science Officer
American Dental Association

Dr. Araujo is Chief Executive Officer of the ADA Science & Research Institute and the ADA Foundation, in addition to providing direct scientific advice to the ADA Board of Trustees and the ADA Chief Science Officer.

Dr. Araujo leads the scientific and dental research activities and manages the research agenda, including ADA policies and programs pertaining to the Council on Scientific Affairs; Center for Evidence-Based Dentistry; Research and Standards ADA Seal of Acceptance and Scientific Information. He provides administrative and scientific guidance within the Institute and agencies of the ADA to address current and emerging scientific issues that affect public health, patient care, dental practice, and national and international health programs. Dr. Araujo serves as the liaison to ADA Foundation Dr. Anthony Volpe Research Center and is the Scientific Advisor to the FDI Science Committee.

Prior to the ADA, Dr. Araujo held Research & Development senior positions in the pharmaceutical industry, both in dentistry as well as other therapeutic areas, including cardiology, nutrition, women’s health, among others, always aiming innovation in healthcare, dissemination of science and improvement of professional education and with academic research. His clinical work has been published in peer review journals, including JADA, benefitting dental practices across the world through global scientific program implementation.

Dr. Araujo held academic positions both in the United States and in Brazil, where he also practiced dentistry in his hometown of Rio de Janeiro. Dr. Araujo received his Doctor in Dental Surgery and earned a Certificate in Periodontology at Universidade Gama Filho in Rio de Janeiro, Brazil. He received his Ph.D. in epidemiology and community health, and Master of Sciences, Oral Sciences from State University of New York at Buffalo, where he also completed a two-and-a-half year Fellowship in Periodontology research and teaching.

Stephanie V. Blank, MD

Director of Gynecological Oncology
Mount Sinai Health System
Professor at Icahn School of Medicine

Dr. Blank, MD, is the Director of Gynecologic Oncology for the Mount Sinai Health System, a Professor in the Department of Obstetrics, Gynecology, and Reproductive Science at the Icahn School of Medicine at Mount Sinai, Director of Oncology Programs for the Blavatnik Family Women’s Health Research Institute and the Director of Women’s Health at the Blavatnik Family – Chelsea Medical Center at Mount Sinai. Dr. Blank, who specializes in the treatment of patients with ovarian, cervical, and uterine cancers, and the care of women at increased genetic risk for gynecologic cancer, joined the Icahn School of Medicine at Mount Sinai in 2017. Previously, she spent 16 years at the NYU Langone Medical Center, where she rose from Assistant to Associate to Full Professor, built a busy clinical practice, launched and ran the Gynecologic Oncology Fellowship Program, developed a cancer risk assessment program for underserved women at Bellevue Hospital, and directed the Gynecologic Oncology Research Program.

Dr. Blank’s research focus is on genetic predisposition to cancer, novel therapeutics and translational research, survivorship, quality of life, and fertility preservation. She serves on the Ovarian Committee of the national cooperative group NRG and has been a principal investigator for investigator-initiated as well as industry-sponsored and cooperative group trials. Dr. Blank is broadly published in peer-reviewed journals and text books and frequently presents at industry seminars and conferences on women’s gynecologic oncology issues. She is the recipient of many honors and awards, including Castle Connolly Top Doctors, Super Doctors, and the Council on Resident Education in Obstetrics and Gynecology Teaching Award, among others.

Dr. Blank serves on numerous boards and committees and is actively involved with many professional organizations, including the Society of Gynecologic Oncology, NRG Oncology, Foundation for Women’s Cancer, American College of Obstetricians and Gynecologists, and the American Society of Clinical Oncology. She is a Member of the American Board of Obstetrics and Gynecology’s Gynecologic Oncology Division, through which she helps set the standards by which gynecologic oncologists are accredited. Additionally, she is a member of the Board of Directors of SHARE and the Medical Advisory Board of the National Ovarian Cancer Coalition.

Dr. Blank received her undergraduate degree from Yale University, majoring in English and Molecular Biophysics and Biochemistry, and her medical degree from the University of California, San Diego, School of Medicine. She completed her residency in Obstetrics and Gynecology at the New York Hospital – Cornell Medical Center and a fellowship in Gynecologic Oncology at the University of Pennsylvania Medical Center. She is a 2020 fellow of the Executive Leadership in Academic Medicine (ELAM) program.

Anna Giuliano, PhD

Professor and Founding
Director of CIIRC
Moffitt Cancer Center

Anna R. Giuliano, PhD, is the founding director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center in Tampa, Florida. She received her doctorate from Tufts University, Boston, Massachusetts, continuing her studies at the New England Epidemiology Institute in Boston and at the University of Arizona in Tucson as a National Cancer Prevention and Etiology Fellow. From 1993 to 1998 she was the recipient of an NIH National Cancer Institute Preventive Oncology Career Development Award.

Dr Giuliano’s career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer in women, and has evolved over the past 30 years to encompass HPV and penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers. Her work has contributed significantly to our understanding of the rate at which HPV infections are acquired and cleared, the proportion that progress to disease, and also to HPV vaccine protection against multiple diseases in women and men.

An expert in the field of cancer research with a longstanding and successful record of National Institutes of Health funding since 1990, she has been actively involved in cancer epidemiology and prevention studies conducted among diverse populations in the United States and abroad. In the course of those endeavors, Dr Giuliano was a contributor to the 1999 Institute of Medicine (IOM) report titled The Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report that concluded for the first time that HPV is a cause of multiple cancers in women and men. Dr. Giuliano has been honored to receive two important awards from the American Cancer Society (ACS).

In 2013, at the ACS 100th anniversary, she was the recipient of the ACS Distinguished Achievement in Cancer Award. In 2018, she was selected for the ACS Clinical Research Professor Award for “Prevention of Infection-Related Cancers.” In 2019, Dr. Giuliano received the American Society of Preventive Oncology (ASPO) Fraumeni Distinguished Lifetime Achievement Award. Dr Giuliano has authored >400 peer-reviewed publications.

Anne Y. Lin, MD, MSHS

Associate Professor of Surgery
David Geffen School of Medicine
UCLA

Dr. Anne Lin is an Associate Professor of Surgery at David Geffen School of Medicine at UCLA. She is a practicing colorectal surgeon and also serves as the Director of Quality for the Division of General Surgery and the Medical Director of Telehealth Programs for UCLA Health.

Dr. Lin works closely with her patients and their families to provide patient-centered and individualized care. She is the recipient of several awards for clinical excellence including “Top Doctor” by Castle Connolly and Super Doctors. Her clinical interests and expertise include colorectal and anal cancer, minimally invasive colorectal surgery (laparoscopic and robotic), inflammatory bowel disease (Crohn's & ulcerative colitis), HPV, and anorectal disorders.

Dr. Lin’s research interests include remote monitoring and innovative technology to improve patient engagement and quality of life, and quality improvement efforts to reduce disparities in adoption of telehealth, surgical site infections and length of stay.

Dr. Lin was recruited to join the UCLA Department of Surgery in 2011. She obtained a Master of Public Health degree from the UCLA Fielding School of Public Health. Dr. Lin attended medical school at Tufts University in Boston and general surgery residency at Brown University. She completed a colorectal research fellowship at Memorial Sloan-Kettering Cancer Center in New York, followed by a colorectal clinical fellowship at Cleveland Clinic Florida. She was an Assistant Professor of Surgery at Washington University School of Medicine in St. Louis from 2007 to 2011 and served as the director of the Inherited Colorectal Cancer Registry. She is a member of the American Board of Colon and Rectal Surgeons and is actively involved with the American Society of Colon and Rectal Surgeons.

Peter Halperin, MD

Clinical Associate Professor
of Dermatology
New York Presbyterian Hospital

Dr. Halperin is a Board-Certified Dermatologist and Dermatologic surgeon. He is recognized by New York Magazine and Castle Connolly's Top Doctors as one of New York's premier Medical and Cosmetic Dermatologists. He helps educate the Cornell Medical students and Dermatology Residents as Clinical Associate Professor of Dermatology at The New York Presbyterian Hospital, Weill Cornell Medical College and Hospital for Special Surgery. He is Past President and on the Board of Governors of the Dermatologic Society of Greater New York. He is Treasurer of the Manhattan Metropolitan Dermatologic Society, a member of the American Academy of Dermatology‘s Professionalism and Ethics Committee and a member of the Physician’s Scientific Society.

Peter graduated Summa Cum Laude from Brandeis University, attended NYU Medical School, and completed his Dermatology Residency training at Weill Cornell New York Hospital, where he was Chief Resident. He volunteers his time at the pediatric clinic at Cornell NY Hospital.

Peter wholeheartedly believes in the goals of the Head and Neck Cancer Alliance (HNCA) and is committed to help the organization foster and promote awareness, early detection and treatment of oral, anogenital, and Head and Neck cancers.

Abraham Aragones, MD

Assistant Professor
Immigrant Health & Cancer Disparities
Memorial Sloan Kettering

Dr. Aragones is an internal medicine physician and public health researcher whose areas of expertise include working with primary care providers to address barriers for cancer screening and prevention among minority and immigrant populations, specifically among the Latino population.

His research interests include understanding primary care providers’ barriers for recommending cancer screening and prevention, designing and implementing interventions tailored to primary care settings and adapted to diverse patient populations, and working with providers in the community serving large Latino populations to design new methods to implement evidence-based interventions into their practice settings.

Dr. Aragones is currently working in the areas of HPV vaccine practices among providers serving large minority populations; developing an intervention to promote the utilization of the HPV vaccine among children of Latino immigrants; and investigating a new model to disseminate and implement evidence-based practices to community physicians serving large Latino populations.

Ashley Burton Arkema

BA, BSN, CNP
Nurse Practitioner
Memorial Sloan Kettering

Ashley Burton Arkema is a Nurse Practitioner in The Female Sexual Medicine and Women’s Health Program (FSMWHP) at Memorial Sloan Kettering Cancer Center (MSKCC). This program provides individual interventions to female cancer patients, women at risk of cancer, and survivors coping with the physical and emotional challenges of cancer treatment. In her current role, she provides care to women experiencing sexual health concerns, including vaginal dryness and pain secondary to their cancer treatment.

Prior to joining MSKCC, she worked in family planning with adolescent girls and a gynecology private practice caring for women across the lifespan. Her academic training includes completing a Bachelor of Arts in Public Health at Purdue University, a Bachelor of Science in Nursing at The University of Miami, and a Master of Science in Nursing at Columbia University. She is also a member of Nurse Practitioners in Women's Health and received additional training from the International Society for the Study of Women's Sexual Health (ISSWSH). Her career goal is to empower female patients and survivors with strategies to improve their quality of life, and she is actively involved in women’s health research, as well as lecturing on this topic with patients and clinicians both within and outside of MSKCC.

Rebecca Jopson LLB, BSc

Radiation Therapist
Rosemere Cancer Centre
Lancashire Hospitals (UK)

After graduating with a degree in Law, Rebecca chose to pursue a career healthcare, completing a BSc (hons) in Radiotherapy at The University of Liverpool in 2019. Currently Rebecca is studying for a MSc in Enhanced Radiotherapy and Oncology whilst working as a radiation therapist at the Rosemere Cancer Centre, Royal Preston Hospital part of Lancashire Teaching Hospitals Trust (LTHTR) NHS, UK.

Rebecca’s interest in HPV and its relationship with cancer began whilst undertaking research for her BSc dissertation. The study was driven by her observations in clinical practice, both in the UK and Canada after completing an elective trip to the London Regional Cancer Program, London Health Science Centre (LHSC), Ontario. Rebecca’s experience highlighted the potential impact of a HPV diagnosis on an individual and their partner, and the variations in support and information available to facilitate open discussion on the topic.

Working with the British Association of Head and Neck Oncologists (BAHNO), Rebecca’s aim was to investigate whether UK healthcare professionals were equipped to provide information and support on HPV to patients diagnosed with cancer of the head and neck. This work has been published in the Journal of Radiotherapy in Practice and has led to opportunities working with experts in HPV related head and neck cancers from the Liverpool Head and Neck Centre. Based on the study findings, Rebecca has also led a project in conjunction with the multidisciplinary head and neck oncology team at LTHTR to implement an education package for healthcare professionals to support their understanding of high risk HPV and its connection to head and neck cancer.

Rebecca is passionate about removing the stigma often associated with HPV, and globally raising awareness by promoting the education of both health professionals and the public around the topic.